l 163191 has been researched along with fedratinib in 1 studies
| Studies (l 163191) | Trials (l 163191) | Recent Studies (post-2010) (l 163191) | Studies (fedratinib) | Trials (fedratinib) | Recent Studies (post-2010) (fedratinib) |
|---|---|---|---|---|---|
| 35 | 0 | 17 | 120 | 16 | 111 |
| Protein | Taxonomy | l 163191 (IC50) | fedratinib (IC50) |
|---|---|---|---|
| Cyclin-G-associated kinase | Homo sapiens (human) | 0.001 | |
| Tyrosine-protein kinase JAK2 | Homo sapiens (human) | 0.0035 | |
| Bromodomain-containing protein 4 | Homo sapiens (human) | 0.29 | |
| Proto-oncogene tyrosine-protein kinase receptor Ret | Homo sapiens (human) | 0.0325 | |
| Tyrosine-protein kinase JAK1 | Homo sapiens (human) | 0.053 | |
| Non-receptor tyrosine-protein kinase TYK2 | Homo sapiens (human) | 0.078 | |
| Receptor-type tyrosine-protein kinase FLT3 | Homo sapiens (human) | 0.02 | |
| Tyrosine-protein kinase JAK3 | Homo sapiens (human) | 0.3917 | |
| AP2-associated protein kinase 1 | Homo sapiens (human) | 0.032 | |
| Bromodomain testis-specific protein | Homo sapiens (human) | 0.34 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
1 other study(ies) available for l 163191 and fedratinib
| Article | Year |
|---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |